Clinical trial
Phase II Study of Stereotactic Body Radiation Therapy for Un-biopsied Early- Stage Non Small Cell Lung Cancer
NCT02950337 is registered in ClinicalTrials.gov with Loyola University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Phase II Study of Stereotactic Body Radiation Therapy for Un-biopsied Early- Stage Non Small Cell Lung Cancer
- Lead sponsor
- Loyola University
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- December 31, 2015
- Completion date
- December 31, 2023
- Enrollment
- 41 (estimated)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
non small cell lung cancer